MyFinsight
Home
About
Contact
Download
Download image
Royalty Contract And
Other Revenue
$317K
Product
$74,063K
Product revenue, net
$74,380K
(37.06%↑ Y/Y)
Income (loss) from
operations
$6,731K
(152.21%↑ Y/Y)
Total costs and
expenses
$67,649K
(0.73%↑ Y/Y)
Net income (loss)
before income taxes
$621K
(103.26%↑ Y/Y)
Total other expense
-$6,110K
(0.96%↑ Y/Y)
Interest and other income
$1,158K
(-3.26%↓ Y/Y)
Amortization of intangible
assets
$2,711K
(0.00%↑ Y/Y)
Selling, general and
administrative
$46,459K
(3.31%↑ Y/Y)
Research and development
$7,483K
(27.09%↑ Y/Y)
Cost of goods sold
$10,996K
(-19.11%↓ Y/Y)
Net income (loss)
$621K
(103.95%↑ Y/Y)
Interest expense
$7,268K
(-6.65%↓ Y/Y)
Comprehensive income (loss)
$620K
(103.94%↑ Y/Y)
Other comprehensive
income (loss), foreign...
-$1K
Back
Back
Income Statement
source: myfinsight.com
xers: the income statement
Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS)